AGENCY:
Drug Enforcement Administration, Justice.
ACTION:
Notice of application.
SUMMARY:
American Radiolabeled Chem has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
DATES:
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before July 26, 2021. Such persons may also file a written request for a hearing on the application on or before July 26, 2021.
ADDRESSES:
Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR 1301.33(a), this is notice that on March 31, 2021, American Radiolabeled Chem, 101 Arc Drive, Saint Louis, Missouri 63146-3502, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substances:
Controlled substance | Drug code | Schedule |
---|---|---|
Gamma Hydroxybutyric Acid | 2010 | I |
Ibogaine | 7260 | I |
Lysergic acid diethylamide | 7315 | I |
Tetrahydrocannabinols | 7370 | I |
Dimethyltryptamine | 7435 | I |
1-[1-(2-Thienyl)cyclohexyl]piperidine | 7470 | I |
Dihydromorphine | 9145 | I |
Heroin | 9200 | I |
Normorphine | 9313 | I |
Amphetamine | 1100 | II |
Methamphetamine | 1105 | II |
Amobarbital | 2125 | II |
Phencyclidine | 7471 | II |
Phenylacetone | 8501 | II |
Cocaine | 9041 | II |
Codeine | 9050 | II |
Dohydrocodeine | 9120 | II |
Oxycodone | 9143 | II |
Hydromorphone | 9150 | II |
Ecgonine | 9180 | II |
Hydrocodone | 9193 | II |
Meperidine | 9230 | II |
Metazocine | 9240 | II |
Methadone | 9250 | II |
Dextropropoxyphene, bulk (non-dosage forms) | 9273 | II |
Morphine | 9300 | II |
Oripavine | 9330 | II |
Thebaine | 9333 | II |
Oxymorphone | 9652 | II |
Phenazocine | 9715 | II |
Carfentanil | 9743 | II |
Fentanyl | 9801 | II |
The company plans to bulk manufacture the listed controlled substances for internal use or for sale to its customers. The company plans to manufacture small quantities of the above-listed controlled substances as radiolabeled compounds for biochemical research. No other activities for these drug codes are authorized for this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-10996 Filed 5-24-21; 8:45 am]
BILLING CODE P